Virology Centre in the Maersk Tower

Mærsk Tower, winter 20216
Nearly 500 square metres on the 14th floor of the Maersk Tower are being equipped as state-of-the-art laboratories. Photo: Lærke Gade Bjerregaard

World-class virus research


The fight against viral diseases begins in the laboratory. The University of Copenhagen is expanding its facilities for virology research.

Viral diseases cause millions of deaths every year and pose a growing threat to global health. The need for new knowledge, vaccines and treatments continues to increase.

The University of Copenhagen's Faculty of Health and Medical Sciences holds a strong position in international virology research. Researchers at the faculty have made groundbreaking discoveries that have contributed to the development of new treatments and vaccines, as well as a deeper understanding of serious viral diseases such as hepatitis and COVID-19.

The university is now strengthening its virology research capacity even further. By 2031, approximately 500 square metres of advanced laboratory facilities will be established on the 14th floor of the Maersk Tower as part of the Department of Immunology and Microbiology. The new facilities will be integrated with existing laboratories and located close to the research environments that will use them.

The laboratories will provide state-of-the-art and secure facilities for research into both known pathogenic viruses and emerging viruses with the potential to cause future epidemics and pandemics. The expanded capacity will strengthen research across the entire spectrum, from fundamental studies of how viruses function and cause disease to the development of new vaccines and treatments in close collaboration with clinical partners and Statens Serum Institut.

The establishment of the new facilities has been supported by a grant of DKK 160 million from the A.P. Møller Foundation. The project is currently in the planning phase, and construction of the facilities on the 14th floor of the Maersk Tower is expected to be completed in 2030-31.